Status:
WITHDRAWN
Influence of the Antioxidant Treatment in the Oxidant-reduction Potential in Seminal Plasma in Men Whose Partners Will Undergo Through an Egg Donation Cycle
Lead Sponsor:
IVI Bilbao
Collaborating Sponsors:
Aytu BioPharma, Inc.
Conditions:
Compare the sORP Rate in Sperm Samples, Obtained by the Mioxsys System, Before and After 2.5 Months Antioxidant Men Supplements Treatment (Fertybiotic Man)
Eligibility:
MALE
18-48 years
Phase:
NA
Brief Summary
Evaluate the influence of antioxidant men supplements treatment (Fertybiotic Hombre) in the rate of sORP (stactic Oxidation Reduction Potential) defined as the balanced measure between the total oxida...
Eligibility Criteria
Inclusion
- Male Inclusion Criteria
- Sperm count greater than 2 million per milliliter
- Sperm origin: ejaculate
- Exclusion Criteria:
- Taking oral antioxidants in the 3 months prior to inclusion in the study
- Total astenozoospermia or Severe teratozoospermia (including balloonzoospermia)
Exclusion
Key Trial Info
Start Date :
February 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 12 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04758260
Start Date
February 12 2019
End Date
February 12 2021
Last Update
February 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IVI Bilbao
Leioa, Vizcaya, Spain, 48940